Breaking News

eClinical Insights Deploys Logi Info in Clinical Applications

April 22, 2014

Aims to deliver simplified reporting and enhanced visualizations for researchers

eClinical Insights, a provider of cloud-based clinical trial intelligence software, has embedded Logi Analytics’ Logi Info into its core applications. Logi Info is designed to deliver comprehensive Business Intelligence (BI) capabilities, simplified reporting and enhanced visualizations for researchers.
According to the company, incorporating Logi Info into its technology platform allows customers to save time building reports. Also, improvements made to the visualizations library, include heat maps, which enables researchers to see adverse effects happening in clinical studies that may have previously been hidden. Researchers can also use sparklines, a Logi feature that helps visualize trending and how subjects are tracking.
"We wanted our customers to spend less time building reports and more time gaining intelligence from them. That was our key criteria when searching for a BI tool, and Logi Analytics was the only company that delivered," said Nick Neri, vice president of product development, eClinical Insights. "The Logi Info Studio is easy enough for the everyday user to develop all the reports they need to do their job. The interface is very straightforward and the visualizations it creates allow our customers to analyze their data in an illuminating way."
"Embedded analytics saves researchers days that were previously spent on building cumbersome reports. Ultimately, that's the goal of analytics – to derive valuable insight from analysis, not to waste precious time with complicated algorithms, complex tools and solutions that no longer fit modern needs," said Brett Jackson, chief executive officer, Logi Analytics. "By leveraging Logi Info, eClinical Insights is empowering its end users with a rich data visualization tool that is accessible to everyone, not just data scientists."

Related Compliance:

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks

  • The Growing Realm of Real-World Data

    Kristin Brooks, Contract Pharma||November 8, 2016
    PPD's Evidera acquisition aims to help clients address the growing demand for evidence from regulators and payers

  • Mastering Immunotherapy Clinical Trials: Dosing and Response

    Mastering Immunotherapy Clinical Trials: Dosing and Response

    Kristin Brooks, Contract Pharma||August 1, 2016
    Andrew Zupnick of Novella Clinical provides insights into dosing and measuring response in immunotherapy clinical trials